what a bunch of mindless drones...just keep adding more and more reps....just makes access worse and the pod mentality is totally outdated and a waste of $$$.
Primary care experience preferred, as no currently employed external oncology rep will want to be one of 7 per territory with new idiot structure. Those that still have decent access won’t much longer come October 1.
Merck doesn't want to pay for external experience. It's easier for them to promote an internal specialty or primary care rep and get them on the cheap.
Oncology brain trust. We are Merck Oncology. We think we know how to run an oncology division since Keytruda is the market leader. Smart clinical trial design vs. Nivo in 1L NSCLC not the reason. Legion of reps must be it. We have no idea how we are perceived by oncologists with 4+ reps swimming in their tiny indication lanes wanting their seat at the clinic lunch table. We don’t value our CTLs and reps to comprehend and discuss more than 2 indications, so we have the brilliant idea of going to 7 teams. We are arrogant to think this will be well accepted by our customers. The territory alignment configured by ZS Associates via computer algorithms ignores account relationships and continuity, and is a cluster—-. This will not end well when the blood drains from your faces as it sinks in you screwed up, and will have to do a RIF. Unless this is part of a grand scheme to provide jobs for the future dissolution of Chronic Care?
Is it me or does anyone else see where Pharma is going? Primary Care calls are no longer needed. Everything is headed toward Oncology. There will be a blood bath of Primary Care reps within the next 3-5 years. Even Oncology will reach a saturation level. Sounds like the Oncology offices are already complaining about the number of reps and here Merck is adding more. Bad move.
